SEI Funds Receive Global Recognition in 2017 OAKS, Pa.,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
66
SEI Funds Receive Global Recognition in 2017

OAKS, Pa., April 11, 2017 (GLOBE NEWSWIRE) -- SEI (NASDAQ: SEIC ) last week announced it received the “Best Group Over Three Years” award in the “Equity Small Company” category at the 2017 Thomson Reuters Lipper Fund Awards in the United Kingdom.  The award recognizes the excellent risk-adjusted performance across SEI’s range of equity funds, which are included in Lipper’s universe of over 3,500 funds provided by over 400 asset managers.

“The UK market is important to SEI, and this award brings valuable recognition as we continue to grow our global presence,” said Kevin Barr, Executive Vice President and Head of Investment Management Unit at SEI. “Our Strategic Portfolio Funds utilize our equity funds and are designed to help investors achieve goals at every stage of life, which is the very core of our goals-based approach.”

“This award is a reflection of the strength of both SEI’s investment process and philosophy, as well as the depth of talent at SEI,” said Jason Collins, Global Head of Equities at SEI. “The ability to add value for investors through our active portfolio management and manager-of-managers approach is the foundation of our investment programs.”

To qualify for an asset class group award, small groups must have at least three distinct portfolios in one of the asset classes – equity, bond, or mixed-asset. SEI’s award-winning equity portfolio range includes regional and global funds; small, mid, and large cap; as well as global managed volatility and smart beta solutions. These funds are actively managed and are core components of SEI’s Goals-Based Strategic Portfolio Funds. 

Last month, two of SEI’s mutual funds were recognized in the US as 2017 Thomson Reuters Lipper Fund Awards  winners at the Lipper Alpha Forum & Fund Awards in New York City. Lipper measures the winners by their risk-adjusted returns over multiple periods. Award winners are rewarded for consistency over time, including the top three-year, five-year and 10-year funds, as well as trophy winners. SEI’s Institutional Investments Trust Dynamic Asset Allocation Fund (SDLAX) was recognized in the Alternative Global Macro Funds Class in the three-year and five-year category, in universes of 71 and 47 funds, respectively, and awarded a trophy for winning in more than one time period. SEI’s Institutional Managed Global Managed Volatility Fund (SVTAX) was recognized in the Global Multi-Cap Core Funds Class in the three-year category in a universe of 48 funds.

SEI’s SIIT Core Fixed Income Fund (SCOAX) was ranked #1 Intermediate-Term Bond fund in its universe of 975 Intermediate-Term Bond Funds by US News and World Report for the one year period ending January 31, 2017. The SIMT Core Fixed Income Fund (TRLVX) was ranked 15 th in its universe of 975 Intermediate-Term Bond Funds by US News and World Report for the one year period ending January 31, 2017.

Additionally, SEI Investments Canada Company recently received Fundata’s FundGrade A+ TM Award for two of its funds for the 2016 calendar year. The SEI Global Managed Volatility Fund, which the Canadian Investment Funds Standards Committee (CIFSC) includes in the “Global Equity” category, was recognized out of 801 funds in this category. The SEI U.S. High Yield Bond Fund, which the CIFSC includes in the “High Yield Fixed Income” category, was recognized out of 237 funds. The FundGrade A+ Award is given annually to investment funds and their managers who have shown consistent, outstanding, risk-adjusted performance through the year.

Performance for the Global Managed Volatility Fund, Class P for the period ended March 31, 2017, is as follows: 11.3% (1 year), 10.3% (3 year), 13.7% (5 year) 13.7 % (since inception March 30, 2012). U.S. High Yield Bond Fund, Class P for the period ended March 31, 2017, is as follows: 17.6% (1 year), 9.0% (3 year), 10.9 % (5 year) 9.9 % (since inception September 11, 2009).

About SEI SEI (NASDAQ: SEIC ) is a leading global provider of investment processing, investment management, and investment operations solutions that help corporations, financial institutions, financial advisors, and ultra-high-net-worth families create and manage wealth. As of December 31, 2016, through its subsidiaries and partnerships in which the company has a significant interest, SEI manages or administers $751 billion in hedge, private equity, mutual fund and pooled or separately managed assets, including $283 billion in assets under management and $468 billion in client assets under administration. For more information, visit seic.com.

Lipper Awards Methodology For a detailed explanation, please review the Lipper Leaders methodology documents on the Lipper Leaders Information page.

I mportant Information Past performance is no guarantee of future results.  Investing involves risk including loss of principal.

To determine if the Funds are an appropriate investment for you, carefully consider the investment objectives, risk factors and charges and expenses before investing.  This and other information can be found in the US-registered Funds’ summary and full prospectuses, which may be obtained by calling 1-800-DIAL-SEI.  Read it carefully before investing.

For those SEI US mutual funds which employ the ‘manager of managers’ structure, SEI Investments Management Corporation (SIMC) has ultimate responsibility for the investment performance of the Funds due to its responsibility to oversee the sub-advisers and recommend their hiring, termination and replacement.  SIMC is the adviser to the SEI US mutual funds, which are distributed by SEI Investments Distribution Co. (SIDCo). SIMC and SIDCo are wholly owned subsidiaries of SEI Investments Company (SEI).

Asset allocation may not protect against market risk. Bonds and bond funds will decrease in value as interest rates rise. High-yield securities may be more volatile, be subject to greater levels of credit or default risk and may be less liquid and more difficult to sell at an advantageous time or price to value than higher-rated securities of similar maturity. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from difference in generally accepted accounting principles or from economic or political instability in other nations. Emerging market involve heightened risks related to the same factors as well as increased volatility and lower trading volume. REIT investments are subject to changes in economic conditions, credit risk and interest rate fluctuations.

Due to its investment strategies, the Dynamic Asset Allocation Fund may buy and sell securities frequently. The use of leverage can amplify the effects of market volatility on the Fund's share price and may also cause the Fund to liquidate portfolio positions when it would not otherwise be advantageous to do so in order to satisfy its obligations. Commodity-linked investments and derivatives may be more volatile and less liquid than direct investments in the underlying commodities themselves. Commodity-related equity returns can also be affected by the issuer's financial structure or the performance of unrelated businesses. The Fund’s use of futures contracts, forward contracts, options and swaps is subject to market risk, leverage risk, correlation risk and liquidity risk.  With short sales, you risk paying more for a security than you received from its sale.  Short sales losses are potentially unlimited and the expense involved with the shorting strategy may negatively impact the performance of the fund.

The SEI Equity Funds (which won the “Best Group Over Three Years” award in the “Equity Small Company” category at the 2017 Thomson Reuters Lipper Fund Awards) and the Strategic Portfolio Funds are Irish domiciled UCITS Funds which are managed by SEI Global Investments, Ltd (“SIGL”) and distributed by SEI Investments (Europe) Ltd (“SIEL”). SIGL and SIEL are wholly owned subsidiaries of SEI. The Shares of these Funds have not been and will not be registered under the Securities Act of 1933 of the United States of America (as amended) (the “1933 Act”) or the securities laws of any of the States of the United States. The Shares may not be offered, sold or delivered directly or indirectly in the United States its territories or possessions or to or for the account or benefit of any U.S. Person as defined in Regulation S under the 1933 Act (“U.S. Person”).

SEI Investments Canada Company, a wholly owned subsidiary of SEI Investments Company, is the Manager of the SEI Funds in Canada.

Commissions, trailing commissions, management fees and expenses all may be associated with mutual fund investments.  Please read the prospectus before investing.  The indicated rates of return are the historical annual compounded total returns including changes in security value and reinvestment of all distributions and do not take into account sales, redemption, distribution or optional charges or income taxes payable by any securityholder that would have reduced returns.  Mutual funds are not guaranteed, their values change frequently and past performance may not be repeated.

About the Fundata FundGrade™ methodology The objective of FundGrade is to rank and grade Canadian investment funds, on a monthly basis, against their peers using risk-adjusted performance metrics. Letter grades from A to E are used. Each month, FundGrade ratings are allocated as follows: 'A' is used for the top 10%; 'B' for the next 20%; 'C' for the middle 40%; 'D' for the next 20%; and 'E' for the bottom 20%. Ratings change on a monthly basis. The FundGrade rating system incorporates up to 10 years of history and uses three risk-adjusted performance metrics that are well known and widely accepted in the investment industry: (1) Sharpe Ratio—a measure of a fund's excess return relative to total risk. It is calculated by subtracting the risk-free rate from the fund's return and dividing by the standard deviation. (2) Sortino Ratio—a measure of a fund's excess return relative to downside risk. It is calculated by subtracting the minimum acceptable return from the fund's return and dividing by the downside deviation. (3) Information Ratio—a measure of a fund's active return relative to its tracking error. It is calculated by subtracting the benchmark return from the fund's return and dividing by the standard deviation of the difference between the return of the fund and the return of the benchmark.

See www.fundata.com/images/FundataFundgradeMethodology.pdf  for specific details of FundGrade's ranking algorithm. To make the grades relevant, funds are only measured against similar investment products with comparable investment mandates. FundGrade uses the fund classification standards that have been defined by the Canadian Investment Funds standards Committee (CIFSC). Funds are ranked and graded within CIFSC categories.

About the FundGrade A+ Methodology The FundGrade A+ Rating is a supplemental calculation to the FundGrade ratings and is performed at the end of each calendar year. Eligible funds must have received a FundGrade rating for each month in the previous calendar year. A score is assigned to each monthly FundGrade rating, as follows: A grade = 4; B grade = 3; C grade = 2; D grade = 1; E grade = 0. For each fund a 'GPA-style' calculation is made by adding up the values for the monthly scores and dividing by 12. Any fund with a GPA of 3.5 or higher receives a FundGrade A+. For specific details of FundGrade's ranking algorithm, see  www.fundata.com/images/FundataFundgradeMethodology.pdf . FundGrade A+ was designed to identify not only the best-performing funds, but also the most consistent.

Company Contact: Dana Grosser SEI +1 610-676-2459 dgrosser@seic.com Media Contact: Leslie Wojcik SEI +1 610-676-4191 lwojcik@seic.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 113

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 352

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 377

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 225

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 119

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 416

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 115

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 349

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 251

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 266

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading

Top 5 Most Recently Viewed Articles

YouTube Shuts Down Tenet Media Channel Amid Legal Issues

Updated Category News Views 305

YouTube's Action Against Tenet Media Explained YouTube, which is part of Alphabet (NASDAQ: GOOGL), has made a significant move by shutting down the Tenet Media channel, along with four other channels managed by Lauren Chen. This decision comes in response to serious legal actions taken by the U.S. Department of Justice against certain individuals involved in money...

Continue Reading
Ardelyx Faces Class Action Lawsuit Amidst Investment Losses

Updated Category News Views 112

Important Update for Ardelyx Investors Regarding Class Action Pomerantz LLP has recently informed shareholders about a class action lawsuit involving Ardelyx, Inc. This lawsuit targets both the company and its key officers, alleging violations of federal securities laws. Investors who held Ardelyx securities during a specified timeframe should pay close attention to this...

Continue Reading
Derek Bryson Park: Innovator Transforming Finance Worldwide

Updated Category News Views 205

Celebrating Derek Bryson Park's Impact on Finance Derek Bryson Park has recently been highlighted by The Enterprise World Magazine as a key figure in the financial industry, a well-deserved recognition for his extensive and impactful career. With three decades of experience, Park continues to innovate in finance, public service, and global diplomacy. Pioneering Leadership...

Continue Reading
Understanding Currency Impacts in Global Trade Dynamics

Updated Category News Views 291

Understanding Currency Impacts in Global Trade Dynamics Scott Bessent, a noted figure in finance, is igniting conversations regarding tariffs and trade in recent discussions. All eyes on Wall Street are focused on how these changes influence market dynamics. Initially, any reduction in the U.S. trade deficit with other nations may seem like a significant win for the...

Continue Reading
Pennant Group Expands Its Operations with Recent Acquisition

Updated Category News Views 283

Pennant Group's Strategic Acquisition Announcement The Pennant Group, Inc. (NASDAQ: PNTG), a prominent holding company in the healthcare industry, recently achieved a significant milestone by acquiring specific operational assets from UnitedHealth Group Incorporated. This notable transaction was made possible due to UnitedHealth’s acquisition of Amedisys Inc., enabling...

Continue Reading